Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis. [electronic resource]
Producer: 20131203Description: 315-25 p. digitalISSN:- 1365-2141
- Aminoglycosides -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease-Free Survival
- Evidence-Based Medicine
- Gemtuzumab
- Hepatic Veno-Occlusive Disease -- chemically induced
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Leukemia, Myelomonocytic, Acute -- drug therapy
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Remission Induction
- Safety-Based Drug Withdrawals
- Survival Analysis
- Treatment Outcome
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.